James Atherton
Johnson University(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Metabolomics and Mass Spectrometry Studies, Antiplatelet Therapy and Cardiovascular Diseases, Drug-Induced Hepatotoxicity and Protection, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451(2005)135 cited
- → Inhibition of Hepatobiliary Transport as a Predictive Method for Clinical Hepatotoxicity of Nefazodone(2006)120 cited
- → Biotransformation: Impact and Application of Metabolism in Drug Discovery(2020)101 cited
- → Determination of Degradation Pathways and Kinetics of Acyl Glucuronides by NMR Spectroscopy(2007)67 cited
- → A Rational Chemical Intervention Strategy To Circumvent Bioactivation Liabilities Associated with a Nonpeptidyl Thrombopoietin Receptor Agonist Containing a 2-Amino-4-arylthiazole Motif(2007)51 cited
- → P2Y1 receptor antagonists as novel antithrombotic agents(2008)51 cited
- → Assessment of the Mass Balance Recovery and Metabolite Profile of Avibactam in Humans and In Vitro Drug-Drug Interaction Potential(2014)50 cited
- → ICI 182,780 Penetrates Brain and Hypothalamic Tissue and Has Functional Effects in the Brain after Systemic Dosing(2008)39 cited
- → Alternate Strategies to Obtain Mass Balance without the Use of Radiolabeled Compounds: Application of Quantitative Fluorine (19F) Nuclear Magnetic Resonance (NMR) Spectroscopy in Metabolism Studies(2012)35 cited
- → Optimization of 5-vinylaryl-3-pyridinecarbonitriles as PKCθ inhibitors(2010)14 cited